Inhibition of SIRT1 combined with gemcitabine therapy for pancreatic carcinoma

Dao-Jun Gong1 Department of Hepatobiliary-Pancreatic Surgery, Jinhua Hospital of Zhejiang University, Jinhua, People’s Republic of China

Jia-Min Zhang1 Department of Hepatobiliary-Pancreatic Surgery, Jinhua Hospital of Zhejiang University, Jinhua, People’s Republic of China

Min Yu1 Department of Hepatobiliary-Pancreatic Surgery, Jinhua Hospital of Zhejiang University, Jinhua, People’s Republic of China

Bo Zhuang1 Department of Hepatobiliary-Pancreatic Surgery, Jinhua Hospital of Zhejiang University, Jinhua, People’s Republic of China

Qing-Qu Guo2 Department of Surgery, Second Affiliated Hospital of Zhejiang University College of Medicine, Hangzhou, People’s Republic of ChinaCorrespondence[email protected]

Pages 889-897 | Published online: 16 Jul 2013

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

LiDXieKWolffRAbbruzzeseJLPancreatic cancerLancet200436394141049105715051286
PubMed Web of Science ®Google Scholar
ZhouJSongSDLiDCZhouJZhuDMZhengSYClinical significance of expression and amplification of the DcR3 gene in pancreatic carcinomaAsian Pac J Cancer Prev201213271972422524850
PubMedGoogle Scholar
IkedaSMaeshirokKRyuSDiagnosis of small pancreatic cancer by endoscopic balloon-catheter spot pancreatography: an analysis of 29 patientsPancreas200938410211319106748
PubMed Web of Science ®Google Scholar
KlaussMStillerWFritzFComputed tomography perfusion analysis of pancreatic carcinomaJ Comput Assist Tomogr201236223724222446366
PubMed Web of Science ®Google Scholar
BurrisHA3rdMooreMJAndersenJImprovements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: A randomized trialJ Clin Oncol1997156240324139196156
PubMed Web of Science ®Google Scholar
BurrisHRocha-LimaCNew therapeutic directions for advanced pancreatic cancer: targeting the epidermal growth factor and vascular endothelial growth factor pathwaysOncologist200813328929818378539
PubMed Web of Science ®Google Scholar
O’ReillyEMAbou-AlfaGKCytotoxic therapy for advanced pancreatic adenocarcinomaSemin Oncol200734434735317674963
PubMed Web of Science ®Google Scholar
von WichertGSeufferleinTAdlerGPalliative treatment of pancreatic cancerJ Dig Dis2008911718251787
PubMed Web of Science ®Google Scholar
GlozakMASetoEHistone deacetylases and cancerOncogene200726375420543217694083
PubMed Web of Science ®Google Scholar
SaundersLRVerdinESirtuins: critical regulators at the crossroads between cancer and agingOncogene200726375489550417694089
PubMed Web of Science ®Google Scholar
HidaYKuboYMuraoKAraseSStrong expression of a longevity-related protein, SIRT1, in Bowen’s diseaseArch Dermatol Res2007299210310617180656
PubMed Web of Science ®Google Scholar
HuffmanDMGrizzleWEBammanMMSIRT1 is significantly elevated in mouse and human prostate cancerCancer Res200767146612661817638871
PubMed Web of Science ®Google Scholar
KuzmichevAMargueronRVaqueroAComposition and histone substrates of polycomb repressive group complexes change during cellular differentiationProc Natl Acad Sci USA200510261859186415684044
PubMed Web of Science ®Google Scholar
YeungFHobergJERamseyCSModulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylaseEMBO J200423122369238015152190
PubMed Web of Science ®Google Scholar
DanoviSAWongHHLemoineNRTargeted therapies for pancreatic cancerBr Med Bull2008879713018753179
PubMed Web of Science ®Google Scholar
KleespiesAJauchKWBrunsCJTyrosine kinase inhibitors and gemcitabine: new treatment options in pancreatic cancer?Drug Resist Updat200691–211816621676
PubMed Web of Science ®Google Scholar
KoAHFuture strategies for targeted therapies and tailored patient management in pancreatic cancerSemin Oncol200734435436417674964
PubMed Web of Science ®Google Scholar
ParselsLAMorganMATanskaDMGemcitabine sensitization by checkpoint kinase 1 inhibition correlates with inhibition of a Rad51 DNA damage response in pancreatic cancer cellsMol Cancer Ther200981455419139112
PubMed Web of Science ®Google Scholar
VanWeeldenKFlanaganLBinderupLTenniswoodMWelshJApoptotic regression of MCF-7 xenografts in nude mice treated with the vitamin D3 analog, EB1089Endocrinology19981394210221109528999
PubMed Web of Science ®Google Scholar
IkejimaMNoguchiSYamashitaRThe zinc fingers of human poly(ADP-ribose) polymerase are differentially required for the recognition of DNA breaks and nicks and the consequent enzyme activation. Other structures recognize intact DNAJ Biol Chem19902653521907219132123876
PubMed Web of Science ®Google Scholar
KaufmannSHDesnoyersSOttavianoYDavidsonNEPoirierGGSpecific proteolytic cleavage of poly(ADP-ribose) polymerase: An early marker of chemotherapy-induced apoptosisCancer Res19935317397639858358726
PubMed Web of Science ®Google Scholar
LazebnikYAKaufmannSHDesnoyersSPoirierGGEarnshawWCCleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICENature199437164953463478090205
PubMed Web of Science ®Google Scholar
TewariMQuanLTO’RourkeKYama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymeraseCell19958158018197774019
PubMed Web of Science ®Google Scholar
YokoyamaYNimuraYNaginoMAdvances in the treatment of pancreatic cancer: limitations of surgery and evaluation of new therapeutic strategiesSurg Today200939646647519468801
PubMed Web of Science ®Google Scholar
PliarchopoulouKPectasidesDPancreatic cancer: current and future treatment strategiesCancer Treat Rev200935543143619328630
PubMed Web of Science ®Google Scholar
TorchilinVPRecent advances with liposomes as pharmaceutical carriersNat Rev Drug Discov20054214516015688077
PubMed Web of Science ®Google Scholar
KalleAMMallikaABadigerJAlinakhiTalukdarPSachchidanandInhibition of SIRT1 by a small molecule induces apoptosis in breast cancer cellsBiochem Biophys Res Commun20104011131920813094
PubMed Web of Science ®Google Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Inhibition of SIRT1 combined with gemcitabine therapy for pancreatic carcinoma

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Inhibition of SIRT1 combined with gemcitabine therapy for pancreatic carcinoma

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date